Delhi Assembly polls: BJP allocates two seats to NDA allies
The Bharatiya Janata Party (BJP) has allotted two seats to its National Democratic Alliance (NDA) allies, Nitish Kumar's ...
BJP to name State president by Jan-end
VIJAYAWADA: The Bharatiya Janata Party (BJP) has initiated the process of appointing a new president for its State wing, ...
Army Day 2025: How to join National Defence Academy (NDA)? Here’s eligibility, exam pattern and more
If joining the Indian Army is your dream, you can make it a reality even with a 12th pass qualification. Read on to know more ...
The Indian Express15d
Yogi minister: ‘Dispute is with a few conspirators in UP govt … STF should be renamed shadyantrakari force’
When the principal secretary was involved in the process and the CMO too knew ... Is the conspirator from the NDA or the Opposition? Because the MLA you are referring to is from the SP. Did that MLA ...
Taiwan News16d
Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain
This streamlined pathway allows for significantly shortened clinical timelines and reduced clinical development costs as compared to the conventional full NDA process. We believe this strategy could ...
Nasdaq16d
Silo Pharma, Inc. Advances Development of SPC-15 and SP-26 with IND Submission Expected in 2025
This streamlined pathway allows for significantly shortened clinical timelines and reduced clinical development costs as compared to the conventional full NDA process. We believe this strategy ...
Mena FN16d
Silo Pharma Issues Letter To Shareholders Detailing Development Progress And Potential For Lead Assets Targeting PTSD And Chronic Pain
This streamlined pathway allows for significantly shortened clinical timelines and reduced clinical development costs as compared to the conventional full NDA process. We believe this strategy ...
Cure Today17d
FDA Accepts NDA for Avutometinib Plus Defactinib in KRAS+ Low-Grade Serous Ovarian Cancer
“With the acceptance of this NDA, we’re taking an important step forward in addressing a condition that has long been overlooked, and we look forward to working with the FDA during its review process ...